Effectiveness of Ecoguided Percutaneous Neuromodulation of the Multipurpose Musculature of L-3 in Non-specific Chronic Lumbar Pain.

Universidad de Almeria

Status: Enrolling

Conditions: Low Back Pain

Treatments: Other: Ultrasound- guided Percutaneous Neuromulation; Other: TENS Therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT03738748

HLA-12

Details and patient eligibility

About

The study evaluates the effectiveness of Ultrasound-guided Percutaneous Neuromodulation in the lumbar multifidus of L3 in non-specific chronic low back pain.

Full description

The effectiveness of neuromoduation in analgesic therapies has been more than contrasted. Considering that multifidus muscles, composed of the spinous transverse rotators muscles and spinous transverse multifidus muscles, are fundamental both for the static and for the dynamics of the lumbar spine, particularly for the region of L-3, the treatment of this musculature with ultrasound-guided percutaneous neuromodulation in patients with nonspecific chronic low back pain must have an analgesic repercussion in this nociceptive process.

Therefore, given that neuromodulation has been considered as a more than effective treatment in painful symptomatology and that diverse scientific literature has proven the activity of the multifida musculature directly affects the stability and mobility of the lumbar spine, it is more than likely interventions with neuromodulative treatments in the multifidus musculature at the level of the third lumbar vertebrae have positive results in Non-specific Chronic Low Back Pain.

Enrollment: 70 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Score ≥4 on the Roland Morris Disability Questionnaire.
• Low back pain for ≥3 months
• Age between 18 and 65 years
• Not undergoing another physical therapy treatment

Exclusion criteria

• Presence of lumbar stenosis
• Diagnosis of spondylolisthesis
• Diagnosis of fibromyalgia
• Treatment with corticosteroid or oral medication within the past two weeks
• A history of spinal surgery
• Contraindication of analgesic electrical therapy
• Having previously received a treatment of electrical analgesia.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

70 participants in 2 patient groups

Ultrasound-guided Percutaneous Neuromodulation

Experimental group

Description:

This group will be treated with percutaneous neuromodulation using a needle with Physio Invasive® device, in its modality of percutaneous electrostimulation for 15 minutes, and guided by ultrasound equipment in the multifidus muscles of L3 (1 times/ 4 weeks).

Treatment:

Other: Ultrasound- guided Percutaneous Neuromulation

TENS therapy

Active Comparator group

Description:

The control group will apply a transcutaneous treatment with surface electrodes with TENS current at 170 Hz for 15 minutes in the L-3 region (1 times/ 4 weeks).

Treatment:

Other: TENS Therapy